Home » RNA Targeting Small Molecule Drug Discovery Market

RNA Targeting Small Molecule Drug Discovery Market By Hit Identification and Screening (High-Throughput Screening, Fragment-Based Screening); By Structural Biology and Computational Chemistry (RNA Structure Prediction, Molecular Docking); By Lead Optimization and Medicinal Chemistry (Chemical Modification, Structure-Activity Relationship Studies); By Biomarker Discovery (Identification of RNA Biomarkers, Diagnostic Applications); By Therapeutic Areas (Oncology, Neurological Disorders); By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions) – Global Industry Insights, Trends, Size, Share, Growth, and Forecast, 2024-2032

Price: $4999

Published: | Report ID: 32766 | Report Format : PDF

Market Insights

  • The global demand for RNA Targeting Small Molecule Drug Discovery was valued at USD 1254.8 million in 2022 and is expected to reach USD 3529.4 Million in 2030, growing at a CAGR of 13.80% between 2023 and 2030.
  • The Server and Data Centre category is predicted to command 51% of the server RNA Targeting Small Molecule Drug Discovery Market in 2022, while the smartphone and tablet segment is expected to grow by 8.4%.
  • Fragment-Based Screening is the fastest growing part in this category, while High-Throughput Screening (HTS) is the leading portion.
  • RNA Structure Prediction categories dominate the processor industry, with Molecular Docking being another significant category.
  • Chemical modification is currently experiencing faster growth.
  • Diagnostic Applications is the fastest-growing subfield. The most important component is the identification of RNA biomarkers.
  • In the RNA Targeting Small Molecule Drug Discovery Market, both Oncology and Neurological Disorders are in high demand.
  • Pharmaceutical and biopharmaceutical companies have vast drug discovery resources and experience, and academic and research institutes are likely to grow rapidly in the global market.
  • North America is expected to hold 60.5% of the market in 2022, while the Asia Pacific region is expected to grow at a constant rate of 20.6% CAGR.
  • Increasing welfare spending and R&D expenditures for the development of novel drug molecules boost market expansion.
  • Financial restrictions and severe government rules stifle market growth.

RNA Targeting Small Molecule Drug Discovery Market

 

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Market Definition

The RNA Targeting Small Molecule Drug Discovery Market refers to the field of research and development focusing on identifying and developing small compounds that can selectively target RNA molecules. These tiny compounds are designed to interact with RNA and affect its activity, which may have therapeutic implications in a variety of disorders. It’s an intriguing area of drug development with the potential to develop novel medicines.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide RNA Targeting Small Molecule Drug Discovery Market will expand at a compound annual growth rate (CAGR) of 13.80%. From USD 1254.8million in 2022, the market is projected to be worth USD 3529.4 million by 2030.

The RNA Targeting Small Molecule Drug Discovery Market is an attractive sector that focuses on producing small compounds that are specially tailored to target RNA molecules. These compounds have the potential to regulate the activity of RNA and provide therapeutic benefits in a variety of disorders. The market is seeing increased attention, investment, and technological developments, paving the door for possible breakthroughs in personalized medicine and the treatment of rare and genetic disorders. Collaboration between academia and industry, as well as regulatory developments, are also driving the growth of this market.

Segmentation by Hit Identification and Screening

  • The fastest growing segment in this category is Fragment-Based Screening. It provides benefits in terms of efficiency and precision.
  • High-Throughput Screening (HTS) is the dominant section. The use of HTS enables the rapid screening of a large number of small compounds.

Segmentation by Structural Biology and Computational Chemistry

  • The RNA Structure Prediction categories dominate the processor market. This part aids in the design of tiny compounds that can interact with RNA targets.
  • Molecular Docking is the another popular segment in the market, which aids in the selection of possible medication candidates.

Segmentation by Lead Optimization and Medicinal Chemistry

  • In the RNA Targeting Small Molecule Drug Discovery Market, chemical modification is currently enjoying quicker growth. It enables the enhancement of the characteristics of lead compounds.

Segmentation by Biomarker Discovery

  • Diagnostic Applications is the fastest-growing area of the RNA Targeting Small Molecule Drug Discovery Market. There is a considerable demand for                  tests.
  • The Identification of RNA Biomarkers is the dominant component, as they act as indications of illness progression or therapy response.

Segmentation by Therapeutic Areas

  • Both the Oncology and Neurological Disorders sectors are in great demand in the RNA Targeting Small Molecule Drug Discovery Market. Oncology is concerned with the treatment of cancer, which is a common and complicated disease. Conditions affecting the nerve system, such as Alzheimer’s, Parkinson’s, and multiple sclerosis, are examples of neurological disorders.

Segmentation by End-User

  • Pharmaceutical and biopharmaceutical companies have extensive resources and experience in drug discovery, and as a result, the segment is expected to continue to dominate the market with a 59.1% revenue share in 2022. Several small to medium-sized biopharmaceutical companies are making inroads into the market.
  • On the other hand, Academic and research institutes are expected to grow at a rapid pace in the global market.

Segmentation by Region

  • North America will own 60.5% of the market in 2022.
  • The Asia Pacific region is predicted to develop at a consistent rate of 20.6% CAGR.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for RNA Targeting Small Molecule Drug Discovery.

RNA Targeting Small Molecule Drug Discovery Market Research

North America will hold maximum share of the market in 2022. The region’s high share is mostly owing to the existence of a large number of the world’s leading pharmaceutical and biopharmaceutical enterprises in the region, including Skyhawk Therapeutics, Inc., Ribometrix, and Arrakis Therapeutics. These companies have the resources and know-how to design and manufacture RNA-targeted therapeutics on a large scale. They are investing much in the development of drugs that target RNA. Furthermore, they have developed ties with regulatory agencies and healthcare providers, both of which are critical for securing regulatory approval and releasing new products. North America also has a well-established healthcare system that facilitates drug research and marketing.

In addition, The Asia Pacific region is expected to exhibit a constant growth rate of 20.6% CAGR in the RNA-targeting small molecule drug discovery business due to increased investments in healthcare infrastructure and R&D activities. The rising prevalence of chronic diseases such as cancer, cardiovascular disease, and neurological disorders is driving the market in this area and has increased demand for cutting-edge RNA-targeted therapies. Governments in the region are also taking steps to promote research and development efforts, which is projected to fuel market expansion even more. Furthermore, rising investment in healthcare infrastructure and the availability of trained labour are likely to drive market expansion in the Asia Pacific region.

Key Highlights of the Report

The global RNA Targeting Small Molecule Drug Discovery Market is segmented by Hit Identification and Screening, Structural Biology and Computational Chemistry,  Lead Optimization and Medicinal Chemistry, Biomarker Discovery, Therapeutic Areas, End-User and region. The RNA Structure Prediction categories dominate the processor market, with Fragment-Based Screening being the fastest growing segment. Furthermore, in the RNA Targeting Small Molecule Drug Discovery Market, Oncology and Neurological Disorders sectors are in high demand, with Asia Pacific leading the market growth.

Growing knowledge of RNA’s function in diseases, technological developments for RNA-targeting drug discovery, and increased need for targeted treatments and precision medicine are the key drivers of the market. Furthermore, the complexity of developing selective and efficacious RNA-targeting drugs, regulatory issues in approving RNA-targeted pharmaceuticals, and little data about the long-term safety and efficacy of RNA-targeting treatments are the key market hurdles.

Nonetheless, In 2022, North America will control 60.5% of the market. Furthermore, the Asia Pacific area is predicted to increase at a consistent rate of 20.6% CAGR..

 What Elements Are Driving the Global Market for RNA Targeting Small Molecule Drug Discovery?

Growing understanding of RNA’s function in diseases, technological developments for RNA-targeting drug discovery, and increased need for targeted treatments and precision medicine are the key market drivers.

What Are The Main Obstacles That The Global RNA Targeting Small Molecule Drug Discovery Market Faces?

The main obstacles to the market are the difficulty of creating effective and selective RNA-targeting medicines, issues with regulatory approval for RNA-targeted drugs, and a paucity of data regarding the long-term safety and effectiveness of RNA-targeting therapies.

What Market Development Prospects Are There For RNA Targeting Small Molecule Drug Discovery Globally?

Potential for developing medications for RNA targets that were previously inaccessible Research groups, business, and academia working together to develop innovative drug discovery techniques and technologies RNA-based medicinal pipeline expansion and the potential to combine medications with other methods

Market Drivers

The global RNA Targeting Small Molecule Drug Discovery Market is driven by several factors. The following are the key drivers of the global RNA Targeting Small Molecule Drug Discovery Market:

Increasing Welfare Spending and R&D Expenditures for the Development of Novel Drug Molecules

The pharmaceutical sector greatly contributes to healthcare by providing medicines and vaccinations for various medical procedures. As a result, annual healthcare spending from business and government budgets has a significant impact on the expansion of the drug discovery process. Healthcare costs are rising rapidly over the world as insurance coverage expands. Hospitals are growing in demand as the number of patients increases.

The amazing increase in healthcare spending, as well as the creation of a wide range of treatment alternatives for patients’ well-being in hospitals and clinics, has increased demand for novel treatments. As a result, it is expected that this component will hasten market expansion. A research published in Pharmaceuticals in February 2020 stated that the FDA has approved the active pharmaceutical ingredients (APIs) for three peptides. According to a study published in BioPharma Trend 2020, the use of artificial intelligence for medicine research is rapidly rising in the pharmaceutical business. This factor is projected to drive significant investment in R&D activities aimed at identifying novel treatment targets that will drive market expansion.

Market Restraints

The global RNA Targeting Small Molecule Drug Discovery Market faces some challenges that may hinder its growth. These include the following:

Financial Constraints And Stringent Government Regulations

The cost of generating a medicine is determined by a wide range of variables, putting a major financial load on drug discovery and development companies. The expenditure of failing medication candidates during trial phases is one of the major causes contributing to high costs. Because the return on investment (ROI) is diminishing, the pharmaceutical industry is under pressure to increase its success rate with limited resources in order to lower the cost of failure. Large firms suffer from long-term losses. Nonetheless, losses have a huge impact on small and medium-sized businesses. As a result, the high capital expense required for drug development, along with the low profit margins, poses a significant obstacle to the drug discovery business.

Opportunities

The global RNA Targeting Small Molecule Drug Discovery Market offers significant growth opportunities. These include the following:

Market Participants Are Becoming More Numerous

The growing demand for small molecule pharmaceuticals is expected to present tempting growth opportunities for industry participants in the global small molecule drug discovery market. BioDuro-Sundia and X-Chem announced the launch of DNA Encoded Compound Library (DEL) technology services in China in August 2022 to assist foreign pharmaceutical companies in finding small molecule medications more swiftly. Chem was a pioneer in DEL technology, and its X-libraries contain over 250 billion tiny compounds.

The growing number of contract research and development organizations is expected to create significant potential opportunities for enterprises in the small molecule drug discovery sector. For instance, in October 2020, PPD Inc. announced its expansion by opening a new multipurpose clinical research facility in Suzhou, China, to provide bioanalytical, biomarker, and vaccine services for clinical trials at all stages of pharmaceutical development.

Competitive Landscape

RNA Targeting Small Molecule Drug Discovery Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global RNA Targeting Small Molecule Drug Discovery Marketis highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Accent Therapeutics
  • Anima Biotech Inc.
  • Arrakis Therapeutics
  • AstraZeneca
  • Epics Therapeutics
  • Expansion Therapeutics
  • Hoffmann-La Roche Ltd
  • H3 Biomedicine Inc.
  • PTC Therapeutics
  • Ribometrix
  • Servier Laboratories
  • Skyhawk Therapeutics, Inc

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global RNA Targeting Small Molecule Drug Discovery Market’s key players continually seek to stay ahead by offering new Hit Identification and Screenings and developments.

In November 2020,  Genentech and Genesis Therapeutics formed a multi-target drug discovery relationship, and AI technology was employed to find new treatment options.

In January 2020, Exscientia, a startup that employs artificial intelligence to uncover new treatments, and Bayer collaborated to create medications for heart and cancer-related disorders.

Summary of Key Findings

  • Financial restrictions and severe government rules stifle market growth.
  • Market segmented by Hit Identification and Screening, Structural Biology and Computational Chemistry,  Lead Optimization and Medicinal Chemistry, Biomarker Discovery, Therapeutic Areas, End-User and region
  • Chemical modification is currently experiencing faster growth.
  • RNA Structure Prediction categories dominate the processor industry
  • North America is leading market growth; the market is highly competitive with key players including Accent Therapeutics; Anima Biotech Inc.; Arrakis Therapeutics; AstraZeneca; Epics Therapeutics.

Future Outlook

  • There is a growing interest in RNA-targeted therapeutics.
  • Increasing research and development investment
  • Technological advancements in RNA-targeting drug discovery
  • Development of RNA-based drug pipelines
  • The possibility of individualized medicine methods
  • Academic-industry collaboration
  • Regulatory advances in RNA-targeted treatments

Segmentation

  • By Hit Identification and Screening:
    • High-Throughput Screening (HTS)
    • Fragment-Based Screening
  • By Structural Biology and Computational Chemistry:
    • RNA Structure Prediction
    • Molecular Docking
  • By Lead Optimization and Medicinal Chemistry:
    • Chemical Modification
    • Structure-Activity Relationship (SAR) Studies
  • By Biomarker Discovery:
    • Identification of RNA Biomarkers
    • Diagnostic Applications
  • By Therapeutic Areas:
    • Oncology
    • Neurological Disorders
  • By End-User:
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Academic and Research Institutions
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global RNA Targeting Small Molecule Drug Discovery Market
2.1.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation
2.1.2. Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening
2.1.3. Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening
2.1.4. Global RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry
2.1.5. Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies
2.1.6. Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies
2.1.7. Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery
2.1.8. Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support
2.1.9. Global RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up
2.1.10. Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services
2.1.11. Global RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas
2.1.12. Global RNA Targeting Small Molecule Drug Discovery Market, By End-User
2.1.13. Global RNA Targeting Small Molecule Drug Discovery Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
3.2.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
3.2.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
3.2.4. Major RNA Targeting Small Molecule Drug Discovery Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Target Identification and Validation
3.5.2. Hit Identification and Screening
3.5.3. Fragment-Based Screening
3.5.4. Lead Optimization and Medicinal Chemistry
3.5.5. Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global RNA Targeting Small Molecule Drug Discovery Market: Company Market Share, Value 2022
4.1.2. Global RNA Targeting Small Molecule Drug Discovery Market: Top 6 Company Market Share, Value 2022
4.1.3. Global RNA Targeting Small Molecule Drug Discovery Market: Top 3 Company Market Share, Value 2022
4.2. Global RNA Targeting Small Molecule Drug Discovery Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global RNA Targeting Small Molecule Drug Discovery Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. RNA Structure Prediction in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on RNA Targeting Small Molecule Drug Discovery Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced RNA Structure Prediction Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation
8.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Target Identification and Validation
8.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Target Identification and Validation, 2022 Vs 2030 (in %)
8.2. Bioinformatics Services
8.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Bioinformatics Services STUDIES, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Bioinformatics Services
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. In vitro Assays
8.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By In vitro Assays, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for In vitro Assays
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening
9.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Hit Identification and Screening
9.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Hit Identification and Screening, 2022 Vs 2030 (in %)
9.2. High-Throughput Screening (HTS)
9.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By High-Throughput Screening (HTS), By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for High-Throughput Screening (HTS)
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
10. Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening
10.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Fragment-Based Screening
10.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Fragment-Based Screening, 2022 Vs 2030 (in %)
10.2. Structural Biology and Computational Chemistry
10.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Structural Biology and Computational Chemistry, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Structural Biology and Computational Chemistry
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. RNA Structure Prediction
10.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By RNA Structure Prediction, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for RNA Structure Prediction
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Molecular Docking
10.4.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Molecular Docking, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Molecular Docking
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
11. Global RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry
11.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, by Lead Optimization and Medicinal Chemistry
11.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Lead Optimization and Medicinal Chemistry, 2022 Vs 2030 (in %)
11.2. Chemical Modification
11.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Chemical Modification, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Chemical Modification
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Structure-Activity Relationship (SAR) Studies
11.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Structure-Activity Relationship (SAR) Studies, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Structure-Activity Relationship (SAR) Studies
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies
12.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies
12.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2022 Vs 2030 (in %)
12.2. ADME-Tox Studies
12.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By ADME-Tox Studies, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for ADME-Tox Studies
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
13. Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies
13.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By In vivo Efficacy Studies
13.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By In vivo Efficacy Studies, 2022 Vs 2030 (in %)
13.2. Animal Models
13.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Animal Models, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Animal Models
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Pharmacogenomics
13.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacogenomics, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Pharmacogenomics
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery
14.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Biomarker Discovery
14.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Biomarker Discovery, 2022 Vs 2030 (in %)
14.2. Identification of RNA Biomarkers
14.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Identification of RNA Biomarkers, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Identification of RNA Biomarkers
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Diagnostic Applications
14.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Diagnostic Applications, By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Diagnostic Applications
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
15. Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support
15.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Clinical Trial Support
15.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Clinical Trial Support, 2022 Vs 2030 (in %)
15.2. Clinical Pharmacology Studies
15.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Pharmacology Studies, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Clinical Pharmacology Studies
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Clinical Monitoring and Data Management
15.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Monitoring and Data Management, By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Clinical Monitoring and Data Management
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up
16.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Manufacturing and Scale-up
16.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Manufacturing and Scale-up, 2022 Vs 2030 (in %)
16.2. Process Development
16.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Process Development, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Process Development
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. GMP (Good Manufacturing Practice) Production
16.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By GMP (Good Manufacturing Practice) Production, By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for GMP (Good Manufacturing Practice) Production
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
17. Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services
17.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Regulatory Affairs Services
17.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Regulatory Affairs Services, 2022 Vs 2030 (in %)
17.2. Regulatory Strategy
17.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Strategy, By Region, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Regulatory Strategy
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
17.3. Preparing Regulatory Documents
17.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Preparing Regulatory Documents, By Region, 2017-2030 (US$ Mn)
17.3.2. Market Dynamics for Preparing Regulatory Documents
17.3.2.1. Drivers
17.3.2.2. Restraints
17.3.2.3. Opportunities
17.3.2.4. Trends
18. Global RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas
18.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By Therapeutic Areas
18.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Therapeutic Areas, 2022 Vs 2030 (in %)
18.2. Oncology
18.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Oncology, By Region, 2017-2030 (US$ Mn)
18.2.2. Market Dynamics for Oncology
18.2.2.1. Drivers
18.2.2.2. Restraints
18.2.2.3. Opportunities
18.2.2.4. Trends
18.3. Neurological Disorders
18.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Neurological Disorders, By Region, 2017-2030 (US$ Mn)
18.3.2. Market Dynamics for Neurological Disorders
18.3.2.1. Drivers
18.3.2.2. Restraints
18.3.2.3. Opportunities
18.3.2.4. Trends
19. Global RNA Targeting Small Molecule Drug Discovery Market, By End-User
19.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, By End-User
19.1.1. Global RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
19.2. Pharmaceutical and Biotechnology Companies
19.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
19.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
19.2.2.1. Drivers
19.2.2.2. Restraints
19.2.2.3. Opportunities
19.2.2.4. Trends
19.3. Contract Research Organizations (CROs)
19.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By High-Throughput Screening (HTS), By Region, 2017-2030 (US$ Mn)
19.3.2. Market Dynamics for High-Throughput Screening (HTS)
19.3.2.1. Drivers
19.3.2.2. Restraints
19.3.2.3. Opportunities
19.3.2.4. Trends
19.4. Academic and Research Institutions
19.4.1. Global RNA Targeting Small Molecule Drug Discovery Market, By High-Throughput Screening (HTS), By Region, 2017-2030 (US$ Mn)
19.4.2. Market Dynamics for High-Throughput Screening (HTS)
19.4.2.1. Drivers
19.4.2.2. Restraints
19.4.2.3. Opportunities
19.4.2.4. Trends
20. Global RNA Targeting Small Molecule Drug Discovery Market, By Region
20.1. Global RNA Targeting Small Molecule Drug Discovery Market Overview, by Region
20.1.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Region, 2022 vs 2030 (in%)
20.2. Target Identification and Validation
20.2.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030 (US$ Mn)
20.3. Hit Identification and Screening
20.3.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030 (US$ Mn)
20.4. Fragment-Based Screening
20.4.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030 (US$ Mn)
20.5. Lead Optimization and Medicinal Chemistry
20.5.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030 (US$ Mn)
20.6. Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies
20.6.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030 (US$ Mn)
20.7. In vivo Efficacy Studies
20.7.1. Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030 (US$ Mn)
20.8. Biomarker Discovery
20.8.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030 (US$ Mn)
20.9. Clinical Trial Support
20.9.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030 (US$ Mn)
20.10. Manufacturing and Scale-up
20.10.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030 (US$ Mn)
20.11. Regulatory Affairs Services
20.11.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030 (US$ Mn)
20.12. Therapeutic Areas
20.12.1. Global RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030 (US$ Mn)
20.13. End-User
20.13.1. Global RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030 (US$ Mn)
21. North America RNA Targeting Small Molecule Drug Discovery Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. North America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. North America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. North America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. North America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. North America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. North America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. North America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. North America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. North America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. North America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
21.11.1. Overview
21.11.2. SRC Analysis
21.12. North America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
21.12.1. Overview
21.12.2. SRC Analysis
21.13. North America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
21.13.1. Overview
21.13.2. SRC Analysis
21.14. North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030(US$ Mn)
21.14.1. North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
21.14.2. U.S.
21.14.3. Canada
21.14.4. Mexico
22. Europe RNA Targeting Small Molecule Drug Discovery Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Europe RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Europe RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Europe RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Europe RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Europe RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Europe RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Europe RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Europe RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Europe RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
22.11.1. Overview
22.11.2. SRC Analysis
22.12. Europe RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
22.12.1. Overview
22.12.2. SRC Analysis
22.13. Europe RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
22.13.1. Overview
22.13.2. SRC Analysis
22.14. Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
22.14.1. Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
22.14.2. UK
22.14.3. France
22.14.4. Germany
22.14.5. Italy
22.14.6. Spain
22.14.7. Benelux
22.14.8. Russia
22.14.9. Rest of Europe
23. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
23.11.1. Overview
23.11.2. SRC Analysis
23.12. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
23.12.1. Overview
23.12.2. SRC Analysis
23.13. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
23.13.1. Overview
23.13.2. SRC Analysis
23.14. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
23.14.1. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
23.14.2. China
23.14.3. Japan
23.14.4. India
23.14.5. South Korea
23.14.6. South East Asia
23.14.7. Rest of Asia Pacific
24. Latin America RNA Targeting Small Molecule Drug Discovery Market Analysis
24.1. Overview
24.1.1. Market Dynamics for North America
24.1.1.1. Drivers
24.1.1.2. Restraints
24.1.1.3. Opportunities
24.1.1.4. Trends
24.2. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
24.2.1. Overview
24.2.2. SRC Analysis
24.3. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
24.3.1. Overview
24.3.2. SRC Analysis
24.4. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
24.4.1. Overview
24.4.2. SRC Analysis
24.5. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
24.5.1. Overview
24.5.2. SRC Analysis
24.6. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
24.6.1. Overview
24.6.2. SRC Analysis
24.7. Latin America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
24.7.1. Overview
24.7.2. SRC Analysis
24.8. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
24.8.1. Overview
24.8.2. SRC Analysis
24.9. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
24.9.1. Overview
24.9.2. SRC Analysis
24.10. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
24.10.1. Overview
24.10.2. SRC Analysis
24.11. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
24.11.1. Overview
24.11.2. SRC Analysis
24.12. Latin America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
24.12.1. Overview
24.12.2. SRC Analysis
24.13. Latin America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
24.13.1. Overview
24.13.2. SRC Analysis
24.14. Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
24.14.1. Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
24.14.2. Brazil
24.14.3. Argentina
24.14.4. Rest of Latin America
25. Middle East RNA Targeting Small Molecule Drug Discovery Market Analysis
25.1. Overview
25.1.1. Market Dynamics for North America
25.1.1.1. Drivers
25.1.1.2. Restraints
25.1.1.3. Opportunities
25.1.1.4. Trends
25.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
25.2.1. Overview
25.2.2. SRC Analysis
25.3. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
25.3.1. Overview
25.3.2. SRC Analysis
25.4. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
25.4.1. Overview
25.4.2. SRC Analysis
25.5. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
25.5.1. Overview
25.5.2. SRC Analysis
25.6. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
25.6.1. Overview
25.6.2. SRC Analysis
25.7. Middle East RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
25.7.1. Overview
25.7.2. SRC Analysis
25.8. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
25.8.1. Overview
25.8.2. SRC Analysis
25.9. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
25.9.1. Overview
25.9.2. SRC Analysis
25.10. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
25.10.1. Overview
25.10.2. SRC Analysis
25.11. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
25.11.1. Overview
25.11.2. SRC Analysis
25.12. Middle East RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
25.12.1. Overview
25.12.2. SRC Analysis
25.13. Middle East RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
25.13.1. Overview
25.13.2. SRC Analysis
25.14. Middle East RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
25.14.1. Middle East RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
25.14.2. UAE
25.14.3. Saudi Arabia
25.14.4. Rest of Middle East
26. Africa RNA Targeting Small Molecule Drug Discovery Market Analysis
26.1. Overview
26.1.1. Market Dynamics for North America
26.1.1.1. Drivers
26.1.1.2. Restraints
26.1.1.3. Opportunities
26.1.1.4. Trends
26.2. Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2030(US$ Mn)
26.2.1. Overview
26.2.2. SRC Analysis
26.3. Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2030(US$ Mn)
26.3.1. Overview
26.3.2. SRC Analysis
26.4. Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2030(US$ Mn)
26.4.1. Overview
26.4.2. SRC Analysis
26.5. Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, 2017-2030(US$ Mn)
26.5.1. Overview
26.5.2. SRC Analysis
26.6. Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2030(US$ Mn)
26.6.1. Overview
26.6.2. SRC Analysis
26.7. Africa RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2030(US$ Mn)
26.7.1. Overview
26.7.2. SRC Analysis
26.8. Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2030(US$ Mn)
26.8.1. Overview
26.8.2. SRC Analysis
26.9. Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2030(US$ Mn)
26.9.1. Overview
26.9.2. SRC Analysis
26.10. Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, 2017-2030(US$ Mn)
26.10.1. Overview
26.10.2. SRC Analysis
26.11. Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2030(US$ Mn)
26.11.1. Overview
26.11.2. SRC Analysis
26.12. Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, 2017-2030(US$ Mn)
26.12.1. Overview
26.12.2. SRC Analysis
26.13. Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2030(US$ Mn)
26.13.1. Overview
26.13.2. SRC Analysis
26.14. Africa RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
26.14.1. Middle East RNA Targeting Small Molecule Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
26.14.2. South Africa
26.14.3. Egypt
26.14.4. Rest of Africa
27. Company Profiles
27.1. General Electric (U.S.).
27.1.1. Company Overview
27.1.2. Types/Services Portfolio
27.1.3. Geographical Presence
27.1.4. SWOT Analysis
27.1.5. Financial Summary
27.1.5.1. Market Revenue and Net Profit (2019-2022)
27.1.5.2. Business Segment Revenue Analysis
27.1.5.3. Geographical Revenue Analysis
27.2. Anima Biotech Inc.
27.3. Arrakis Therapeutics
27.4. AstraZeneca
27.5. Epics Therapeutics
27.6. Expansion Therapeutics
27.7. Hoffmann-La Roche Ltd
27.8. H3 Biomedicine Inc.
27.9. PTC Therapeutics
27.10. Ribometrix
27.11. Servier Laboratories
27.12. Skyhawk Therapeutics, Inc
28. Research Methodology
28.1. Research Methodology
28.2. Structural Biology and Computational Chemistry – Secondary Research
28.3. Structural Biology and Computational ChemistryI – Data Modelling
28.3.1. Company Share Analysis Model
28.3.2. Revenue Based Modelling
28.4. Structural Biology and Computational ChemistryII – Primary Research
28.5. Research Limitations
28.5.1. Assumptions

List of Figures
FIG. 1 Global RNA Targeting Small Molecule Drug Discovery Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global RNA Targeting Small Molecule Drug Discovery Market Segmentation
FIG. 4 Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2022 (US$ Mn)
FIG. 5 Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2022 (US$ Mn)
FIG. 6 Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2022 (US$ Mn)
FIG. 7 Global RNA Targeting Small Molecule Drug Discovery Market, by Lead Optimization and Medicinal Chemistry, 2022 (US$ Mn)
FIG. 8 Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2022 (US$ Mn)
FIG. 9 Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2022 (US$ Mn)
FIG. 10 Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2022 (US$ Mn)
FIG. 11 Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2022 (US$ Mn)
FIG. 12 Global RNA Targeting Small Molecule Drug Discovery Market, by Manufacturing and Scale-up, 2022 (US$ Mn)
FIG. 13 Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2022 (US$ Mn)
FIG. 14 Global RNA Targeting Small Molecule Drug Discovery Market, by Therapeutic Areas, 2022 (US$ Mn)
FIG. 15 Global RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2022 (US$ Mn)
FIG. 16 Global RNA Targeting Small Molecule Drug Discovery Market, by Geography, 2022 (US$ Mn)
FIG. 17 Attractive Investment Proposition, By Target Identification and Validation, 2022
FIG. 18 Attractive Investment Proposition, By Hit Identification and Screening, 2022
FIG. 19 Attractive Investment Proposition, By Fragment-Based Screening, 2022
FIG. 20 Attractive Investment Proposition, By Lead Optimization and Medicinal Chemistry, 2022
FIG. 21 Attractive Investment Proposition, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2022
FIG. 22 Attractive Investment Proposition, By In vivo Efficacy Studies, 2022
FIG. 23 Attractive Investment Proposition, By Biomarker Discovery, 2022
FIG. 24 Attractive Investment Proposition, By Clinical Trial Support, 2022
FIG. 25 Attractive Investment Proposition, By Manufacturing and Scale-up, 2022
FIG. 26 Attractive Investment Proposition, By Regulatory Affairs Services, 2022
FIG. 27 Attractive Investment Proposition, By Therapeutic Areas, 2022
FIG. 28 Attractive Investment Proposition, By End-User, 2022
FIG. 29 Attractive Investment Proposition, by Geography, 2022
FIG. 30 Global Market Share Analysis of Key RNA Targeting Small Molecule Drug Discovery Market Manufacturers, 2022
FIG. 31 Global Market Positioning of Key RNA Targeting Small Molecule Drug Discovery Market Manufacturers, 2022
FIG. 32 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Target Identification and Validation, 2022 & 2030 (Value %)
FIG. 33 Global RNA Targeting Small Molecule Drug Discovery Market, by Bioinformatics Services, Value, 2017-2030 (US$ Mn)
FIG. 34 Global RNA Targeting Small Molecule Drug Discovery Market, by In vitro Assays, Value, 2017-2030 (US$ Mn)
FIG. 35 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Hit Identification and Screening, 2022 & 2030 (Value %)
FIG. 36 Global RNA Targeting Small Molecule Drug Discovery Market, by High-Throughput Screening (HTS), Value, 2017-2030 (US$ Mn)
FIG. 37 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Fragment-Based Screening, 2022 & 2030 (Value %)
FIG. 38 Global RNA Targeting Small Molecule Drug Discovery Market, by Structural Biology and Computational Chemistry, Value, 2017-2030 (US$ Mn)
FIG. 39 Global RNA Targeting Small Molecule Drug Discovery Market, by RNA Structure Prediction, Value, 2017-2030 (US$ Mn)
FIG. 40 Global RNA Targeting Small Molecule Drug Discovery Market, by Molecular Docking, Value, 2017-2030 (US$ Mn)
FIG. 41 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Lead Optimization and Medicinal Chemistry, 2022 & 2030 (Value %)
FIG. 42 Global RNA Targeting Small Molecule Drug Discovery Market, by Chemical Modification, Value, 2017-2030 (US$ Mn)
FIG. 43 Global RNA Targeting Small Molecule Drug Discovery Market, by Structure-Activity Relationship (SAR) Studies, Value, 2017-2030 (US$ Mn)
FIG. 44 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2022 & 2030 (Value %)
FIG. 45 Global RNA Targeting Small Molecule Drug Discovery Market, by ADME-Tox Studies, Value, 2017-2030 (US$ Mn)
FIG. 46 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By In vivo Efficacy Studies, 2022 & 2030 (Value %)
FIG. 47 Global RNA Targeting Small Molecule Drug Discovery Market, by Animal Models, Value, 2017-2030 (US$ Mn)
FIG. 48 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmacogenomics, Value, 2017-2030 (US$ Mn)
FIG. 49 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Biomarker Discovery, 2022 & 2030 (Value %)
FIG. 50 Global RNA Targeting Small Molecule Drug Discovery Market, by Identification of RNA Biomarkers, Value, 2017-2030 (US$ Mn)
FIG. 51 Global RNA Targeting Small Molecule Drug Discovery Market, by Diagnostic Applications, Value, 2017-2030 (US$ Mn)
FIG. 52 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Clinical Trial Support, 2022 & 2030 (Value %)
FIG. 53 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Pharmacology Studies, Value, 2017-2030 (US$ Mn)
FIG. 54 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Monitoring and Data Management, Value, 2017-2030 (US$ Mn)
FIG. 55 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Manufacturing and Scale-up, 2022 & 2030 (Value %)
FIG. 56 Global RNA Targeting Small Molecule Drug Discovery Market, by Process Development, Value, 2017-2030 (US$ Mn)
FIG. 57 Global RNA Targeting Small Molecule Drug Discovery Market, by GMP (Good Manufacturing Practice) Production, Value, 2017-2030 (US$ Mn)
FIG. 58 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Regulatory Affairs Services, 2022 & 2030 (Value %)
FIG. 59 Global RNA Targeting Small Molecule Drug Discovery Market, by Regulatory Strategy, Value, 2017-2030 (US$ Mn)
FIG. 60 Global RNA Targeting Small Molecule Drug Discovery Market, by Preparing Regulatory Documents, Value, 2017-2030 (US$ Mn)
FIG. 61 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By Therapeutic Areas, 2022 & 2030 (Value %)
FIG. 62 Global RNA Targeting Small Molecule Drug Discovery Market, by Oncology, Value, 2017-2030 (US$ Mn)
FIG. 63 Global RNA Targeting Small Molecule Drug Discovery Market, by Neurological Disorders, Value, 2017-2030 (US$ Mn)
FIG. 64 Global RNA Targeting Small Molecule Drug Discovery Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 65 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 66 Global RNA Targeting Small Molecule Drug Discovery Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 67 Global RNA Targeting Small Molecule Drug Discovery Market, by Academic and Research Institutions, Value, 2017-2030 (US$ Mn)
FIG. 68 North America RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 69 U.S. RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 70 Canada RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 71 Mexico RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 72 Europe RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 73 Germany RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 74 France RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 75 U.K. RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 76 Italy RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 77 Spain RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 78 Benelux RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 79 Russia RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 80 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 81 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 82 China RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 83 Japan RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 84 India RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 85 South Korea RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 86 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 87 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 88 Latin America RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 89 Brazil RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 90 Argentina RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 91 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 92 Middle East RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 93 UAE RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 94 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 95 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 96 Africa RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 97 South Africa RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 98 Egypt RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 99 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global RNA Targeting Small Molecule Drug Discovery Market
TABLE 2 Global RNA Targeting Small Molecule Drug Discovery Market: Drivers Impact Analysis
TABLE 3 Global RNA Targeting Small Molecule Drug Discovery Market: Market Restraints Impact Analysis
TABLE 4 Global RNA Targeting Small Molecule Drug Discovery Market, by Competitive Benchmarking, 2022
TABLE 5 Global RNA Targeting Small Molecule Drug Discovery Market, by Geographical Presence Analysis, 2022
TABLE 6 Global RNA Targeting Small Molecule Drug Discovery Market, by Key Strategies Analysis, 2022
TABLE 7 Global RNA Targeting Small Molecule Drug Discovery Market, by Bioinformatics Services, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global RNA Targeting Small Molecule Drug Discovery Market, by Bioinformatics Services, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global RNA Targeting Small Molecule Drug Discovery Market, by In vitro Assays, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global RNA Targeting Small Molecule Drug Discovery Market, by In vitro Assays, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global RNA Targeting Small Molecule Drug Discovery Market, by High-Throughput Screening (HTS), By Region, 2017-2022 (US$ Mn)
TABLE 12 Global RNA Targeting Small Molecule Drug Discovery Market, by High-Throughput Screening (HTS), By Region, 2023-2030 (US$ Mn)
TABLE 13 Global RNA Targeting Small Molecule Drug Discovery Market, by Structural Biology and Computational Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global RNA Targeting Small Molecule Drug Discovery Market, by Structural Biology and Computational Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global RNA Targeting Small Molecule Drug Discovery Market, by RNA Structure Prediction, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global RNA Targeting Small Molecule Drug Discovery Market, by RNA Structure Prediction, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global RNA Targeting Small Molecule Drug Discovery Market, by Molecular Docking, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global RNA Targeting Small Molecule Drug Discovery Market, by Molecular Docking, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global RNA Targeting Small Molecule Drug Discovery Market, by Chemical Modification, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global RNA Targeting Small Molecule Drug Discovery Market, by Chemical Modification, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global RNA Targeting Small Molecule Drug Discovery Market, by Structure-Activity Relationship (SAR) Studies, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global RNA Targeting Small Molecule Drug Discovery Market, by Structure-Activity Relationship (SAR) Studies, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global RNA Targeting Small Molecule Drug Discovery Market, by ADME-Tox Studies, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global RNA Targeting Small Molecule Drug Discovery Market, by ADME-Tox Studies, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global RNA Targeting Small Molecule Drug Discovery Market, by Animal Models, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global RNA Targeting Small Molecule Drug Discovery Market, by Animal Models, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmacogenomics, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmacogenomics, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global RNA Targeting Small Molecule Drug Discovery Market, by Identification of RNA Biomarkers, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global RNA Targeting Small Molecule Drug Discovery Market, by Identification of RNA Biomarkers, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global RNA Targeting Small Molecule Drug Discovery Market, by Diagnostic Applications, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global RNA Targeting Small Molecule Drug Discovery Market, by Diagnostic Applications, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Pharmacology Studies, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Pharmacology Studies, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Monitoring and Data Management, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global RNA Targeting Small Molecule Drug Discovery Market, by Clinical Monitoring and Data Management, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global RNA Targeting Small Molecule Drug Discovery Market, by Process Development, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global RNA Targeting Small Molecule Drug Discovery Market, by Process Development, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global RNA Targeting Small Molecule Drug Discovery Market, by GMP (Good Manufacturing Practice) Production, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global RNA Targeting Small Molecule Drug Discovery Market, by GMP (Good Manufacturing Practice) Production, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global RNA Targeting Small Molecule Drug Discovery Market, by Regulatory Strategy, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global RNA Targeting Small Molecule Drug Discovery Market, by Regulatory Strategy, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global RNA Targeting Small Molecule Drug Discovery Market, by Preparing Regulatory Documents, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global RNA Targeting Small Molecule Drug Discovery Market, by Preparing Regulatory Documents, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global RNA Targeting Small Molecule Drug Discovery Market, by Oncology, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global RNA Targeting Small Molecule Drug Discovery Market, by Oncology, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global RNA Targeting Small Molecule Drug Discovery Market, by Neurological Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global RNA Targeting Small Molecule Drug Discovery Market, by Neurological Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 50 Global RNA Targeting Small Molecule Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 51 Global RNA Targeting Small Molecule Drug Discovery Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 52 Global RNA Targeting Small Molecule Drug Discovery Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 53 Global RNA Targeting Small Molecule Drug Discovery Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 54 Global RNA Targeting Small Molecule Drug Discovery Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 55 Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 56 Global RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 57 Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 58 Global RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 59 Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 60 Global RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 61 Global RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 62 Global RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 63 Global RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 64 Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 65 Global RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 66 Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 67 Global RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 68 Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 69 Global RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 70 Global RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 71 Global RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 72 Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 73 Global RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 74 Global RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 75 Global RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 76 Global RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 77 Global RNA Targeting Small Molecule Drug Discovery Market, by Region, 2017-2022 (US$ Mn)
TABLE 78 Global RNA Targeting Small Molecule Drug Discovery Market, by Region, 2023-2030 (US$ Mn)
TABLE 79 North America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 80 North America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 81 North America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 82 North America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 83 North America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 84 North America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 85 North America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 86 North America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 87 North America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 88 North America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 89 North America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 90 North America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 91 North America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 92 North America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 93 North America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 94 North America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 95 North America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 96 North America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 97 North America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 98 North America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 99 North America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 100 North America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 101 North America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 102 North America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 103 North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2022 (US$ Mn)
TABLE 104 North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2023-2030 (US$ Mn)
TABLE 105 United States RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 106 United States RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 107 United States RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 108 United States RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 109 United States RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 110 United States RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 111 United States RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 112 United States RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 113 United States RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 114 United States RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 115 United States RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 116 United States RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 117 United States RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 118 United States RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 119 United States RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 120 United States RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 121 United States RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 122 United States RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 123 United States RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 124 United States RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 125 United States RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 126 United States RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 127 United States RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 128 United States RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 129 Canada RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 130 Canada RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 131 Canada RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 132 Canada RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 133 Canada RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 134 Canada RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 135 Canada RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 136 Canada RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 137 Canada RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 138 Canada RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 139 Canada RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 140 Canada RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 141 Canada RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 142 Canada RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 143 Canada RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 144 Canada RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 145 Canada RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 146 Canada RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 147 Canada RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 148 Canada RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 149 Canada RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 150 Canada RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 151 Canada RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 152 Canada RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 153 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 154 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 155 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 156 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 157 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 158 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 159 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 160 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 161 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 162 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 163 Mexico RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 164 Mexico RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 165 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 166 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 167 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 168 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 169 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 170 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 171 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 172 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 173 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 174 Mexico RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 175 Mexico RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 176 Mexico RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 177 Europe RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 178 Europe RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 179 Europe RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 180 Europe RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 181 Europe RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 182 Europe RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 183 Europe RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 184 Europe RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 185 Europe RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 186 Europe RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 187 Europe RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 188 Europe RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 189 Europe RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 190 Europe RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 191 Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 192 Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 193 Europe RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 194 Europe RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 195 Europe RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 196 Europe RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 197 Europe RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 198 Europe RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 199 Europe RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 200 Europe RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 201 Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2017-2022 (US$ Mn)
TABLE 202 Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2023-2030 (US$ Mn)
TABLE 203 Germany RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 204 Germany RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 205 Germany RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 206 Germany RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 207 Germany RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 208 Germany RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 209 Germany RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 210 Germany RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 211 Germany RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 212 Germany RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 213 Germany RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 214 Germany RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 215 Germany RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 216 Germany RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 217 Germany RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 218 Germany RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 219 Germany RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 220 Germany RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 221 Germany RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 222 Germany RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 223 Germany RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 224 Germany RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 225 Germany RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 226 Germany RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 227 France RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 228 France RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 229 France RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 230 France RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 231 France RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 232 France RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 233 France RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 234 France RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 235 France RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 236 France RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 237 France RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 238 France RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 239 France RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 240 France RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 241 France RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 242 France RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 243 France RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 244 France RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 245 France RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 246 France RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 247 France RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 248 France RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 249 France RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 250 France RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 251 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 252 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 253 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 254 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 255 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 256 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 257 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 258 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 259 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 260 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 261 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 262 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 263 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 264 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 265 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 266 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 267 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 268 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 269 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 270 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 271 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 272 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 273 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 274 United Kingdom RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 275 Italy RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 276 Italy RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 277 Italy RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 278 Italy RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 279 Italy RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 280 Italy RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 281 Italy RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 282 Italy RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 283 Italy RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 284 Italy RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 285 Italy RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 286 Italy RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2023-2030 (US$ Mn)
TABLE 287 Italy RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 288 Italy RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 289 Italy RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 290 Italy RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 291 Italy RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 292 Italy RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 293 Italy RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 294 Italy RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 295 Italy RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 296 Italy RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 297 Italy RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 298 Italy RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 299 Spain RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 300 Spain RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 301 Spain RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 302 Spain RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 303 Spain RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 304 Spain RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 305 Spain RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 306 Spain RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 307 Spain RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 308 Spain RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 309 Spain RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 310 Spain RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 311 Spain RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 312 Spain RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 313 Spain RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 314 Spain RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 315 Spain RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 316 Spain RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 317 Spain RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 318 Spain RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 319 Spain RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 320 Spain RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 321 Spain RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 322 Spain RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 323 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 324 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 325 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 326 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 327 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 328 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 329 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 330 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 331 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 332 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 333 Benelux RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 334 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 335 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 336 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 337 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 338 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 339 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 340 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 341 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 342 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 343 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 344 Benelux RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 345 Benelux RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 346 Benelux RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 347 Russia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 348 Russia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 349 Russia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 350 Russia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 351 Russia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 352 Russia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 353 Russia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 354 Russia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 355 Russia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 356 Russia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 357 Russia RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 358 Russia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 359 Russia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 360 Russia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 361 Russia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 362 Russia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 363 Russia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 364 Russia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 365 Russia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 366 Russia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 367 Russia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 368 Russia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 369 Russia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 370 Russia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 371 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 372 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 373 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 374 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 375 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 376 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 377 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 378 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 379 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 380 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 381 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 382 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 383 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 384 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 385 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 386 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 387 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 388 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 389 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 390 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 391 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 392 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 393 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 394 Rest of Europe RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 395 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 396 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 397 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 398 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 399 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 400 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 401 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 402 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 403 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 404 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 405 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 406 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 407 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 408 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 409 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 410 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 411 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 412 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 413 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 414 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 415 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 416 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 417 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 418 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 419 China RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 420 China RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 421 China RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 422 China RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 423 China RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 424 China RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 425 China RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 426 China RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 427 China RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 428 China RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 429 China RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 430 China RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 431 China RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 432 China RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 433 China RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 434 China RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 435 China RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 436 China RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 437 China RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 438 China RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 439 China RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 440 China RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 441 China RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 442 China RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 443 Japan RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 444 Japan RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 445 Japan RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 446 Japan RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 447 Japan RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 448 Japan RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 449 Japan RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 450 Japan RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 451 Japan RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 452 Japan RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 453 Japan RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 454 Japan RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 455 Japan RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 456 Japan RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 457 Japan RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 458 Japan RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 459 Japan RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 460 Japan RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 461 Japan RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 462 Japan RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 463 Japan RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 464 Japan RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 465 Japan RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 466 Japan RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 467 India RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 468 India RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 469 India RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 470 India RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 471 India RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 472 India RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 473 India RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 474 India RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 475 India RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 476 India RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 477 India RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 478 India RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 479 India RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 480 India RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 481 India RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 482 India RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 483 India RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 484 India RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 485 India RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 486 India RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 487 India RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 488 India RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 489 India RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 490 India RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 491 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 492 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 493 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 494 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 495 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 496 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 497 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 498 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 499 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 500 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 501 South Korea RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 502 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 503 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 504 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 505 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 506 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 507 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 508 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 509 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 510 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 511 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 512 South Korea RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 513 South Korea RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 514 South Korea RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 515 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 516 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 517 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 518 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 519 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 520 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 521 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 522 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 523 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 524 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 525 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 526 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 527 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 528 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 529 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 530 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 531 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 532 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 533 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 534 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 535 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 536 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 537 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 538 South-East Asia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 539 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 540 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 541 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 542 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 543 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 544 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 545 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 546 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 547 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 548 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 549 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 550 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 551 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 552 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 553 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 554 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 555 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 556 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 557 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 558 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 559 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 560 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 561 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 562 Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 563 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 564 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 565 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 566 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 567 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 568 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 569 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 570 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 571 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 572 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 573 Latin America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 574 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 575 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 576 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 577 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 578 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 579 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 580 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 581 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 582 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 583 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 584 Latin America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 585 Latin America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 586 Latin America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 587 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 588 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 589 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 590 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 591 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 592 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 593 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 594 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 595 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 596 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 597 Brazil RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 598 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 599 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 600 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 601 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 602 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 603 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 604 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 605 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 606 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 607 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 608 Brazil RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 609 Brazil RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 610 Brazil RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 611 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 612 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 613 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 614 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 615 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 616 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 617 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 618 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 619 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 620 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 621 Argentina RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 622 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 623 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 624 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 625 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 626 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 627 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 628 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 629 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 630 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 631 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 632 Argentina RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 633 Argentina RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 634 Argentina RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 635 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 636 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 637 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 638 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 639 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 640 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 641 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 642 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 643 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 644 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 645 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 646 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 647 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 648 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 649 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 650 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 651 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 652 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 653 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 654 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 655 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 656 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 657 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 658 Rest of Latin America RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 659 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 660 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 661 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 662 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 663 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 664 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 665 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 666 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 667 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 668 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 669 Middle East RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 670 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 671 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 672 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 673 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 674 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 675 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 676 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 677 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 678 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 679 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 680 Middle East RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 681 Middle East RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 682 Middle East RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 683 UAE RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 684 UAE RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 685 UAE RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 686 UAE RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 687 UAE RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 688 UAE RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 689 UAE RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 690 UAE RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 691 UAE RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 692 UAE RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 693 UAE RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 694 UAE RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 695 UAE RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 696 UAE RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 697 UAE RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 698 UAE RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 699 UAE RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 700 UAE RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 701 UAE RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 702 UAE RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 703 UAE RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 704 UAE RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 705 UAE RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 706 UAE RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 707 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 708 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 709 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 710 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 711 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 712 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 713 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 714 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 715 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 716 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 717 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 718 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 719 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 720 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 721 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 722 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 723 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 724 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 725 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 726 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 727 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 728 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 729 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 730 Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 731 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 732 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 733 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 734 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 735 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 736 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 737 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 738 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 739 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 740 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 741 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 742 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 743 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 744 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 745 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 746 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 747 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 748 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 749 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 750 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 751 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 752 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 753 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 754 Rest of Middle East RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 755 Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 756 Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 757 Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 758 Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 759 Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 760 Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 761 Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 762 Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 763 Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 764 Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 765 Africa RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 766 Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 767 Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 768 Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 769 Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 770 Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 771 Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 772 Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 773 Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 774 Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 775 Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 776 Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 777 Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 778 Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 779 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 780 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 781 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 782 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 783 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 784 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 785 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 786 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 787 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 788 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 789 South Africa RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 790 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 791 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 792 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 793 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 794 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 795 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 796 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 797 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 798 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 799 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 800 South Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 801 South Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 802 South Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 803 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 804 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 805 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 806 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 807 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 808 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 809 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 810 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 811 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 812 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 813 Egypt RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 814 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 815 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 816 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 817 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 818 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 819 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 820 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 821 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 822 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 823 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 824 Egypt RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 825 Egypt RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 826 Egypt RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)
TABLE 827 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 828 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 829 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2017-2022 (US$ Mn)
TABLE 830 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Hit Identification and Screening, 2023-2030 (US$ Mn)
TABLE 831 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2017-2022 (US$ Mn)
TABLE 832 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Fragment-Based Screening, 2023-2030 (US$ Mn)
TABLE 833 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 834 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Lead Optimization and Medicinal Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 835 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2017-2022 (US$ Mn)
TABLE 836 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, 2023-2030 (US$ Mn)
TABLE 837 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By In vivo Efficacy Studies, 2017-2022 (US$ Mn)
TABLE 838 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 839 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 840 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 841 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2017-2022 (US$ Mn)
TABLE 842 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Clinical Trial Support, 2023-2030 (US$ Mn)
TABLE 843 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2017-2022 (US$ Mn)
TABLE 844 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Manufacturing and Scale-up, By Region, 2023-2030 (US$ Mn)
TABLE 845 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2017-2022 (US$ Mn)
TABLE 846 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Regulatory Affairs Services, 2023-2030 (US$ Mn)
TABLE 847 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2017-2022 (US$ Mn)
TABLE 848 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By Therapeutic Areas, By Region, 2023-2030 (US$ Mn)
TABLE 849 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2017-2022 (US$ Mn)
TABLE 850 Rest of Africa RNA Targeting Small Molecule Drug Discovery Market, By End-User, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current Structural Biology and Computational Chemistry of the worldwide RNA Targeting Small Molecule Drug Discovery Market?

In 2022, the global RNA Targeting Small Molecule Drug Discovery Market is expected to be worth USD 1254.8million.

What is the predicted growth rate of the RNA Targeting Small Molecule Drug Discovery Market between 2023 and 2030?

The RNA Targeting Small Molecule Drug Discovery Market is estimated to increase at a CAGR of 13.80% between 2023 and 2030, reaching USD 3529.4 Million in 2030.

Which segment has the most market share in terms of Structural Biology and Computational Chemistry?

In 2022, the RNA Structure Prediction categories dominate the processor industry

Which Therapeutic Areas segment governs the market demand for RNA Targeting Small Molecule Drug Discovery?

The Oncology and Neurological Disorders sectors are both in high demand in the RNA Targeting Small Molecule Drug Discovery Market.

Who are the major players in the global RNA Targeting Small Molecule Drug Discovery Market?

The top players include Accent Therapeutics; Anima Biotech Inc.; Arrakis Therapeutics; AstraZeneca; Epics Therapeutics.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN